Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

406 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial.
Kahaly GJ, Riedl M, König J, Pitz S, Ponto K, Diana T, Kampmann E, Kolbe E, Eckstein A, Moeller LC, Führer D, Salvi M, Curro N, Campi I, Covelli D, Leo M, Marinò M, Menconi F, Marcocci C, Bartalena L, Perros P, Wiersinga WM; European Group on Graves' Orbitopathy (EUGOGO). Kahaly GJ, et al. Among authors: marcocci c. Lancet Diabetes Endocrinol. 2018 Apr;6(4):287-298. doi: 10.1016/S2213-8587(18)30020-2. Epub 2018 Jan 31. Lancet Diabetes Endocrinol. 2018. PMID: 29396246 Clinical Trial.
Graves' ophthalmopathy: a preventable disease?
Bartalena L, Marcocci C, Pinchera A. Bartalena L, et al. Among authors: marcocci c. Eur J Endocrinol. 2002 Apr;146(4):457-61. doi: 10.1530/eje.0.1460457. Eur J Endocrinol. 2002. PMID: 11916611 Review.
Orbital radiotherapy for Graves' ophthalmopathy.
Bartalena L, Marcocci C, Tanda ML, Rocchi R, Mazzi B, Barbesino G, Pinchera A. Bartalena L, et al. Among authors: marcocci c. Thyroid. 2002 Mar;12(3):245-50. doi: 10.1089/105072502753600223. Thyroid. 2002. PMID: 11952048 Review.
Management of thyroid eye disease.
Bartalena L, Marcocci C, Tanda L, Pinchera A. Bartalena L, et al. Among authors: marcocci c. Eur J Nucl Med Mol Imaging. 2002 Aug;29 Suppl 2:S458-65. doi: 10.1007/s00259-002-0813-6. Epub 2002 May 8. Eur J Nucl Med Mol Imaging. 2002. PMID: 12192546 Review.
Current medical management of Graves ophthalmopathy.
Marcocci C, Bartalena L, Marinò M, Rocchi R, Mazzi B, Menconi F, Morabito E, Pinchera A. Marcocci C, et al. Ophthalmic Plast Reconstr Surg. 2002 Nov;18(6):402-8. doi: 10.1097/00002341-200211000-00003. Ophthalmic Plast Reconstr Surg. 2002. PMID: 12439051 Review. No abstract available.
Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience.
Prummel MF, Bakker A, Wiersinga WM, Baldeschi L, Mourits MP, Kendall-Taylor P, Perros P, Neoh C, Dickinson AJ, Lazarus JH, Lane CM, Heufelder AE, Kahaly GJ, Pitz S, Orgiazzi J, Hullo A, Pinchera A, Marcocci C, Sartini MS, Rocchi R, Nardi M, Krassas GE, Halkias A. Prummel MF, et al. Among authors: marcocci c. Eur J Endocrinol. 2003 May;148(5):491-5. doi: 10.1530/eje.0.1480491. Eur J Endocrinol. 2003. PMID: 12720530
Long-term safety of orbital radiotherapy for Graves' ophthalmopathy.
Marcocci C, Bartalena L, Rocchi R, Marinò M, Menconi F, Morabito E, Mazzi B, Mazzeo S, Sartini MS, Nardi M, Cartei F, Cionini L, Pinchera A. Marcocci C, et al. J Clin Endocrinol Metab. 2003 Aug;88(8):3561-6. doi: 10.1210/jc.2003-030260. J Clin Endocrinol Metab. 2003. PMID: 12915636
Preferential megalin-mediated transcytosis of low-hormonogenic thyroglobulin: a control mechanism for thyroid hormone release.
Lisi S, Pinchera A, McCluskey RT, Willnow TE, Refetoff S, Marcocci C, Vitti P, Menconi F, Grasso L, Luchetti F, Collins AB, Marino M. Lisi S, et al. Among authors: marcocci c. Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):14858-63. doi: 10.1073/pnas.2432267100. Epub 2003 Dec 1. Proc Natl Acad Sci U S A. 2003. PMID: 14657389 Free PMC article.
406 results